Introduction
The prevention of medication errors (MEs) and adverse drug events (ADEs) in hospitals is recognised internationally as an important healthcare priority [1] . A systematic review of eight studies from the USA, UK, New Zealand, Australia and Canada found that the median incidence rate of in-hospital adverse events was 9.2% of patients, with ADEs found to be common, accounting for 15.1% of adverse events [2] . Other systematic reviews have examined the frequency of prescribing errors (PEs), medication administration errors (MAEs) and dispensing errors (DEs) in hospitals worldwide, with reported median rates of error being 7% (interquartile range [IQR] 2.0-14.0) of medication orders, 19.0% (IQR 8.6-28.3) of total opportunities for error (OE), and a range of 0.1-2.7% for items dispensed, respectively [3] [4] [5] . Whilst these reviews have contributed to our understanding of the extent and nature of medication-related problems in general hospitals, these estimates cannot be assumed to represent more specialist settings, such as mental health hospitals, where different patient population characteristics and ways of working may create medication safety challenges distinct from those seen in general hospital settings [6] [7] [8] .
Patients with serious mental illness have a set of vulnerabilities and risks associated with the nature of mental illnesses and pharmacological treatment [6, 7, 9] . For instance, the cognitive impairment associated with mental illness may be associated with non-adherence with medical treatment and poor reporting of medication-related problems [8, 10, 11] . In addition, mental healthcare practice also differs with regard to the unique medicines-related legislation, such as the UK Mental Health Act 1983 (amended 2007), which requires strict documentation of prescribing practice and allows administration of treatment for mental disorders against the patient's will [12] . The type of medications used and the way in which these medicines are managed in mental health may also create unique safety challenges. For example, psychotropic medication such as antipsychotics, antidepressants and benzodiazepines are used frequently in the hospitalised mental health population, many of which contribute to physical health problems such as impaired glucose tolerance, dyslipidaemia, sexual dysfunction and extrapyramidal side effects [6, 9, 13, 14] . Polypharmacy [15] , highdose antipsychotic prescribing [16, 17] and drug-drug/-drug-disease interactions are also prevalent in the mental health population [18] , which can increase the risk of medication-related problems.
Taking all these issues into account, the need to explore the burden of medicines safety issues in mental health hospitals is therefore warranted. Earlier literature reviews have focussed on MEs and/or ADEs exclusively in mental health hospitals [8, [19] [20] [21] , but only three of these were systematic in nature [19] [20] [21] . Whilst informative, these reviews are now outdated as more recent publications relating to ME and ADE in mental health hospitals have emerged [22] [23] [24] [25] . They were also restricted to English language publications [19, 20] or were specific to elderly patients [20] , which limits understanding across wider mental health settings and populations. Some of these earlier reviews also included studies that reported error rates based on incident report data [26, 27] , which are known to underestimate error rates substantially [28] , or focussed exclusively on MEs without consideration of ADEs [19, 20] . Therefore, the aim of this systematic review was to provide an up-to-date and critical assessment of the frequency and nature of ME and ADE in mental health hospitals.
Method

Definitions
ADEs were defined as ''any injury resulting from medical intervention related to a drug'' [29, 30] , and those associated with MEs were classified as preventable ADEs (pADEs). MEs were defined according to the National Coordinating Council for Medication Error Reporting and Prevention (NCCMERP) as ''any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient, or consumer. Such events may be related to professional practice, health care products, procedures, and systems, including prescribing, order communication, product labelling, packaging, and nomenclature, compounding, dispensing, distribution, administration, education, monitoring, and use'' [31] . Unintentional medication discrepancies were also examined and defined as ''unexplained differences in documented medication regimens at the point of transition of care'' [32] .
Search Strategy
We searched ten electronic databases from January 1999 to October 2016: MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature (CINAHL), International Pharmaceutical Abstracts (IPA), PsycINFO, Scopus, British Nursing Index (BNI), Applied Social Science Index and Abstract (ASSIA), Web of Science, and Cochrane Database of Systematic Reviews. The start date of the search was selected to coincide with the publication of the landmark report To Err Is Human: Building a Safer Health System [33] , which is generally considered to have instigated extensive patient safety research [34] , and also to ensure that the included studies related to current medication safety practices in mental health hospitals. For each database, the search keywords used were divided into three groups: error-related terms (including error(s), medication error(s), medical error, drug error, treatment error, therapeutic error, medication safety, drug safety, drug-related problem, adverse drug event, preventable adverse drug event, potential adverse drug event, near miss, medication incident, clinical incident, drug incident, incident report, prescribing error, prescription error, administration error, dispensing error, transcription error, omission, discrepancy), epidemiology-related terms (including rate, prevalence, incidence), and setting-related terms (including psychiatry, psychiatric hospital, mental health hospital, adult psychiatry, child psychiatry, adolescent psychiatry, geriatric psychiatry and forensic psychiatry). The reference lists of all included articles and relevant reviews were also examined to identify any additional studies that could be eligible for inclusion. Any additional studies identified by the project team were also included as long as they fulfilled the study's inclusion criteria. Study authors were contacted when additional information was required.
Inclusion and Exclusion Criteria
Inclusion Criteria
Studies published between 1999 and October 2016 that reported the rate of MEs/ADEs in one or more stage(s) of the treatment process (prescribing, administration, transcription, dispensing and monitoring) for patients in mental health hospitals (in-patient and outpatient services) were included, as were studies that examined the rate of unintentional medication discrepancies at the point of transition of care between mental health hospitals and other settings (such as primary care). However, studies that failed to differentiate between intentional and unintentional discrepancies using a robust method (e.g. by contacting the medical team) were not included. In addition, studies that examined the impact of interventions on ME or ADE rates were only included if a baseline error rate could be determined. Conference abstracts were included if they provided data sufficient to allow the rate of ME or ADE to be calculated.
Exclusion Criteria
Studies that utilised incident reports as the primary source of collecting data were excluded (as they greatly underestimate the error rate) [28] , as were those that used an estimated denominator to calculate the rate of ME or ADE (as the provided rate may not be reflective of the actual rate) [3] . Studies that reported ME or ADE rates for a single drug, single drug class or disease were excluded, as were studies that only examined specific prescribing, administration, transcription or DE subtypes, such as wrong dose. Studies that reported the rate of potentially inappropriate prescribing (PIP) in mental health hospitals were excluded, as they were not considered to be MEs [35] . Whilst review articles were excluded, we screened the reference lists of any identified reviews to identify other relevant studies.
Data Extraction
A standardized data collection form was developed and used to collect information concerning publication year, country of origin, study setting, definitions used, study design (retrospective or prospective) and error detection method. In addition, information related to the main findings of the study, including the rate of MEs or ADEs (including the rate of pADEs), type of denominator used, type of errors, class of medication involved, and severity of reported errors, was also retrieved. For each study, data were extracted by two of the authors independently, with any disagreements in extraction being resolved by discussion between all authors.
Quality Assessment
The quality of the included studies was assessed on the basis of criteria originally developed by Allan and Barker [36] , which has been used in other systematic reviews of medication safety [37] [38] [39] , including one in mental health settings [20] . The criteria require a clear description of the following: aim/objectives of the study, outcome definition, error categories specified, error categories defined, denominator, data collection method, study setting, validity and reliability measures used, and consideration of study limitations.
Data Analysis
The included studies were heterogeneous in nature, which prevented any meta-analysis of data. Although a comparable denominator (OE) was observed among studies reporting MAE rates, differences in study setting and types of administration error being studied meant that pooled analysis was not appropriate; therefore, the findings were summarised narratively. The percentage rate of ME was determined by dividing the number of actual errors that occurred or number of patients/prescriptions affected by MEs by the total number of prescriptions/patients/OE multiplied by 100. The rate of ADE/pADE per 1000 patient days was calculated by dividing number of ADEs/pADEs by the total number of patient days multiplied by 1000.
Literature Search Results
In all, 20 unique studies were included in this systematic review, as shown in Fig. 1 . Six studies examined overall ME rates [40] [41] [42] [43] [44] [45] , including two that measured ADEs [42, 44] and some studies also reporting additional data on PEs [40] [41] [42] [43] 45] , MAEs [40] [41] [42] 45] , transcription errors (TEs) [40, 42, 43] and DEs [41, 43, 45] . In total, 14 studies reported data on the rate of PE [22, 23, [40] [41] [42] [43] [45] [46] [47] [48] [49] [50] [51] [52] , one on unintentional discrepancies [53] , and eight on MAEs [24, 25, 40-42, 45, 54, 55] . A summary of the characteristics of the included studies is presented in Table 1 .
Quality Assessment
The aim and objectives for each study were clearly stated and definitions provided for MEs/ADEs in all (n = 16 [80%]) but four studies [43, 48, 52, 53] . ME categories were specified in all ME studies and defined in one study [41] . The denominators were explicitly described in all studies. The data collection method and study setting were also described clearly in all studies. A process of validation to confirm the error had occurred was applied in 11 (55%) studies [22-25, 40, 42-44, 46, 47, 53] , all of which used different approaches to error validation. Reliability measures were applied only in three studies (15%) [41, 42, 44] . In terms of study limitations, only five studies did not state key limitation(s) [43, 46, 47, 51, 54] , three of which were conference abstracts [43, 46, 54] . Conference abstracts made quality assessment of study reporting challenging, as the nature of abstracts precludes sufficient information for such an assessment. A summary of the quality assessment criteria is shown in Table 2 .
Frequency of Medication Errors and Adverse Drug Events
Overall Rates of Medication Errors and Adverse Drug Events
Six studies reported an overall ME rate covering all stages of the medication treatment process from prescribing through to dispensing (Table 1 ). Of these, two studies examined both MEs and ADEs [42, 44] , and some studies also reported additional data on the rate of ME categories, including PEs [40] [41] [42] [43] 45] , MAEs [40] [41] [42] 45] , TEs [40, 42, 43] and DEs [41, 43, 45] . Three studies were prospective [42, 43, 45] , two studies used both a retrospective and a prospective design [40, 41] and one study used retrospective chart review [44] .
Five studies used different error definitions, including the definition of ME developed by Bates et al. [42, 44] , Reason [41] and the NCCMERP [40, 45] . One study did not provide any error definition [43] . Additional variability was apparent in the denominators used, the study setting (inpatient or outpatient), the patient population (child or adult), and data collection methods, which limited our ability to compare the studies directly. Four studies used different health professions to collect data such as nurses, pharmacists, physicians or psychiatrists [40, [42] [43] [44] . The remaining two studies did not specify the professional role of the data collector [41, 45] . Two studies with similar denominators reported an overall ME rate of 10.6-17.5 per 1000 patient-days [42, 44] . Other studies found that MEs occured in 2.4% of complete prescriptions checked (in a paediatric outpatient setting) [43] , 17.4% of total OE [41] and in 61.4% of patients [45] . MEs commonly occurred during prescribing [42, 44] , transcription [43] and medication administration stages [40, 41, 45] and also occurred due to a lack of treatment monitoring [44] . Psychotropic therapy was most often associated with error (41.0-68.0%), particularly involving atypical antipsychotics (19.3-32.0%) [41, 42, 44] . In child outpatient settings, methylphenidate and trihexyphenidyl were most frequently associated with error [43] . The assessment of potential severity was carried out either by using the NCCMERP criteria [45] or based on methods used in other published studies [41, 42] . Data on ME severity found that 28.0-50.7% of errors were of significant severity, 42.3-44.8% were of serious severity and 2.1-4.4% were potentially life threatening [41, 42] .
In terms of ADEs, two studies undertaken in the USA and Japan reported rates of 10.0-42.0 per 1000 patientdays, and 10.8-213.0 per 100 admissions, respectively [42, 44] . Preventable ADE rates accounted for 13.0-17.3% of all ADEs giving a rate of 1.3-7.3 per 1000 patient-days and 1.3-37.1 per 100 admissions, respectively [42, 44] . Chart review and incident report were the two methods used to detect ADEs [40, 42] . One study also used pharmacy and nurse report to detect ADEs [42] . The study from Japan [44] found the incidence rate of ADEs was higher in medical care units-where psychiatric patients with physical comorbidities are more likely to be treated-than in acute and nursing units. Psychotropic medicines were commonly involved with ADEs (79.8-92.0%), including the pADE subset (58.4-68%). Atypical antipsychotic medicines were the most common psychotropic class associated with ADEs [42, 44] . The severity of ADEs was commonly rated as significant (66.0-71.0%), serious (28.0-31.0%) or life-threatening (1.4-2.0%) [42, 44] . For pADEs, the corresponding severity ratings were significant 68.0%, serious 24.0 and 8.0% life threatening in the US study [42] . Full-text articles excluded, with reasons (n = 26)
• 4 review articles • 11 studies with no denominator/error given • 2 discrepancy studies without using a robust method to distinguish between intentional/unintentional discrepancies • 1 study used estimated denominator • 3 studies that relied solely on incident report as method for collecting data • 1 study on single mental health disease • 2 Potential inappropriate prescribing studies • 2 abstract that did not provide sufficient data for inclusion 
Prescribing Errors
In total, 14 studies reported data concerning the frequency of PEs, making it the most frequent error type studied [22, 23, 40-43, 45, 46-52] . A total of 50.0% of studies [22, 23, 46, 47, [49] [50] [51] used the PE definition proposed by Dean et al. [56] , namely ''a clinically meaningful prescribing error occurs when, as a result of a prescribing decision or prescription writing process, there is an unintentional significant (1) reduction in the probability of treatment being timely and effective or (2) increase in the risk of harm when compared with generally accepted practice''. However, in the mental health setting, several additional clinical scenarios were added to adapt this definition, including prescribing a drug without registering a patient with the drug company and performing the necessary monitoring (e.g. for clozapine) or prescribing a drug to mental health patients without a Mental Health Act form authorization. One study [41] used the definition of a PE by Lisby et al. [57] , and the remaining six studies (42.8%) did not state any definition at all [40, 42, 43, 45, 48, 52] . The majority of studies (n = 10 [71.4%]) were conducted prospectively [22, 23, 42, 43, [45] [46] [47] [49] [50] [51] except for four studies that used a retrospective design [40, 41, 48, 52] . All studies were conducted in inpatient settings except two studies that took place in an outpatient setting [43, 50] and another which took place across both inpatients and outpatients [45] . Chart review was the method used for detecting PEs by all studies except one study which also used incident reports and nurse/pharmacy staff reports [42] .
Pharmacists collected the data in six studies [22, 23, [46] [47] [48] [49] , a combination of health care professionals were used in three studies [40, 42, 43] and physicians in one study [52] . Four studies did not specify the professional status of the data collectors [41, 45, 50, 51] . The presence of PE was confirmed either by using one reviewer (medical director) in one study [40] or a panel of healthcare professionals in four studies [22, 23, 42, 46, 47] ; the rest did not report any process of error validation [41, 43, 45, [48] [49] [50] [51] [52] . Across the studies, there were differences in the types of denominator used to determine PE rates. Three studies (one focused on PEs on hospital discharge) [23] provided the PE rate per newly written or omitted item checked, the rate of which ranged from 4.5 to 6.3% [22, 23, 46] . A further three PE studies reported a rate of errors for all prescription items affected by PEs, with a rate range of 2.2-91.6% [47, 49, 51] . A range of 52.2-82.1% of patients [45, 52] , 7.2-165 per 1000 patient-days [40, 42] and 4.0% of total OE were also reported [41] (see Table 1 ). In paediatric outpatient setting, the rate of PE was 0.9% of complete prescriptions checked [43] . There was more than one type of ME in prescriptions (the total number of MEs identified is more than the number of prescriptions/items examined Two studies from the UK found that senior physicians were more likely than more junior physicians to make PEs [22, 23] . In addition, the use of an electronic prescription pro forma and the number of medication items prescribed were found to increase the risk of PEs on discharge prescriptions [23] . The most frequent PEs reported involved the omission of regularly prescribed medication (12.5%) [22] , missing or incorrect dose (23.3%) [46] and writing incomplete prescriptions [47, 49] . Three studies found that psychotropic therapies were more commonly associated with PEs [23, 41, 49] , in contrast to two studies that found that non-psychotropic therapy was commonly involved, particularly antimicrobial medication [46, 47] . The severity of harm classified for most PEs was potentially significant (9.0-49.3%) or minor (27.0-44.0%). Some PEs were assessed as having the potential to cause serious harm (3.3-40%) or even death (0.3-20%) if not prevented [22, 23, 41, 49] .
Unintentional Medication Discrepancy
One study investigated the rate of unintentional discrepancy at the time of hospital admission for 382 patients [53] . Medication chart review was conducted prospectively by a pharmacy technician to detect discrepancies. The medication discrepancies were validated by approaching the clinical team involved with each identified discrepancy. In total, 56% of hospital admissions were associated with unintentional medication discrepancies. Increasing age and polypharmacy were found to increase the risk of unintentional medication discrepancy at hospital admission. Drug omission was the most frequent type of discrepancy reported (77.2%), followed by wrong/unclear dose prescribed (7.0%). The potential severity of unintentional medication discrepancies was rated as moderate in 37.7% and minor in 62.3% of cases [53] .
Transcription errors
Three studies investigated the rate of transcription errors with two studies conducted in the US [40, 42] and one study conducted in Thailand [43] . Two studies used chart review to detect TEs [40, 43] , whereas the other used a combination of chart review, incident report review and pharmacy and nurse staff reports [42] . All studies were conducted in inpatient settings [40, 42] except one study that took place in an outpatient paediatric setting [43] . None of these studies provided a definition of transcription error. However, two studies specified transcription error categories [40, 43] . Two studies used nurse, pharmacist, and physician data collectors [42, 43] and the other used nurse and pharmacist data collectors [40] . The reported rate of TE was between 1.1-344 per 1000 patient-days [40, 42, 43] . Situations in which the medication order was not transcribed [40] or transcribed incorrectly [40, 43] were found to be the most common TE subtypes reported.
Medication Administration Errors
Eight studies assessed the rate of MAEs. All studies [24, 25, 54, 55] used the MAE definition developed by Baker et al [61] except two studies, one of which [41] used the definition proposed by Lisby et al. [57] , and the other three studies did not state any definition [40, 42, 45] . Six studies used a prospective design [24, 25, 41, 42, 45, 54] , and one was conducted retrospectively [40] . One study used both a retrospective and a prospective design to detect MAE [55] . Direct observation was the most common method for detecting MAEs, representing the sole data collection method in four studies [24, 25, 41, 54] . Two studies relied only on chart review to detect error [40, 45] , while the other two studies used a combination of the above methods in addition to incident reports [55] and nurse and pharmacy reports [42] . Pharmacists collected the data in four studies [24, 25, 54, 55] , a pharmacy director and nurse in two studies [40, 42] , whereas the remaining studies did not specify the professional status of the data collector [41, 45] . In three studies, MAEs were validated independently either by senior pharmacists [24, 25] or by a medical director [40] , and the remaining two studies used a consensus meeting of the research team [42, 55] .
The total OE was used as the error denominator by most MAE studies [24, 25, 41, 54, 55] , except for three that used patient-days [40, 42] or number of patients [45] as the denominator. The Barker et al. definition of OE was used by three studies [24, 25, 54] , and the remaining studies either developed their own definition [41] or did not state any [55] . The rate of MAEs reported in studies using similar denominators ranged from 3.3 to 48.0% of total OE [24, 25, 41, 54, 55 ], 1.0-997.0 per 1000 patient-days [40, 42] or 97.7% of patients [45] . One study found that greater numbers of interruptions, patients on the ward, doses administered, and medication doses due significantly increased the rate of MAEs [25] . Other factors, such as nonoral route of medication administration, presence of organic brain disease (e.g. dementia), swallowing difficulties or patients who regularly refused to take their medication were associated with MAEs in elderly patients [55] . Wrong time errors (1.9-39.2%) and drug omissions (7.5-57%) were reported to be the two most common MAE types identified across the studies [24, 25, 41, 45, 54, 55] . Only two studies examined whether psychotropic or non-psychotropic drugs were more likely to be related to MAEs; their conclusions were conflicting [41, 55] . Severity ratings varied across the studies, with 7.3-71.0% classified as minor severity and 0.3-5.0% as potentially serious [24, 25, 41, 55] .
Dispensing Errors
The rate of DEs was assessed by three studies [41, 43, 45] . Two studies were conducted in an adult inpatient setting [41, 45] and one took place in an outpatient paediatric setting [43] . Dispensing errors were detected by direct observation and unannounced control visits in one study [41] and by chart review in two studies [43, 45] . In adult inpatient settings, DE reported rates were 4.6% of total OE [41] and 8.8% of patients [45] , while the reported rate in paediatric outpatient setting was 0.2% of complete prescriptions checked [43] . The most common types of DE were wrong medication brand (87.5%), dose omission (50.0%), and incorrect labelling of medication (22.0%) [41, 45] . The potential severity was assessed in one study using two senior clinical pharmacologists; 61.1% of DE were assessed as having potentially clinically significant effects, with the remainder classed as potentially serious [41] .
Discussion
Our systematic review found that MEs in mental health hospitals are common and do cause harm to psychiatric patients. Such risks affect multiple stages of the medication use process (prescribing, dispensing and administration) and are common at points of care transfer and outpatient hospital settings. Of the 20 studies identified, only two examined actual harm due to medication use.
The reported ranges of ME and ADE rates in mental health hospitals appear to overlap with reported IQRs of MEs and ADEs in general hospitals [3] [4] [5] . However, the risk associated with these errors differed according to the type of medication involved. Psychotropic medication was found to be more frequently associated with MEs and ADEs than were non-psychotropic medicines. Atypical antipsychotics were the most common class of psychotropic medication involved with ADEs and MEs [42, 44] . In general hospitals, analgesics [29] , anti-infective agents [58, 59] and cardiovascular medications were commonly associated with ADEs [60] , whereas anti-infectives [3] and cardiovascular and gastrointestinal medications [4] were found to be more often associated with PEs and MAEs, respectively. Therefore, understanding the risks associated with psychotropic medicines is crucial for improving safety in mental health hospitals.
Drug omission, incorrect dose and wrong time errors were by far the most commonly observed ME subtypes in mental health hospitals. This is similar to results reported in systematic reviews of PE and MAE in general hospitals [3, 4, 39] . Other evidence from the US also found that wrong time error, drug omission, and incorrect dose were the three most common types of MEs in 36 healthcare facilities [61] . Future research should target these types of MEs to improve medication safety in mental health hospitals.
The majority of studies assessed the severity of MEs and ADEs. However, variations in the scales used to assess severity precluded direct comparisons. This variability has also been recognised as a limitation in other reviews of MEs [3, 4] . For studies that used a similar assessment scale, the majority of MEs that caused actual patient harm were of significant severity [42, 44] . Future research should seek standardization between severity assessment scales to allow for direct comparison.
We found that around 65.0% of the included studies were conducted after 2006, highlighting that research examining MEs and ADEs in mental health settings is a developing area. In addition, the majority of ME studies were conducted in the UK, [22-25, 46, 47, 49, 52-55] , whereas only a few were published in other Western (Denmark, USA) [40] [41] [42] and Asian (Japan, Thailand, Pakistan and India) regions [43-45, 50, 51] . To gain deeper insight into the scale of MEs in mental health hospitals, it is important to obtain additional epidemiological evidence from other countries, which would be important in understanding the differences in healthcare practices within mental health hospitals from a global perspective. In terms of ADEs, only two studies from the USA and Japan have investigated the frequency of ADEs [42, 44] ; as no information is available from other countries, this should be considered an important target for future research.
Overall, whilst the included studies varied in terms of outcome definitions and research methods, it is important to highlight the emerging consistency in study design that has been achieved in studies investigating ADE, PE and MAE emerging recently. For instance, in MAE studies based in the UK, consistency was achieved in terms of the data collection method (direct observation, a recognised gold standard) [62] and denominator used (OE, the most common in the wider literature) [4] . PE studies (also based in the UK) used similar PE definitions [56] , denominators (newly omitted and written items [n = 3 studies]) [22, 23, 46] and data collection methods (chart review) [22, 23, 40, 41, [46] [47] [48] [49] [50] [51] [52] . Such homogeneity could be used as a benchmark for ongoing research projects in the field as well as to facilitate comparisons of ME rates in mental health hospitals. Greater standardisation in study methodology is needed, not only to support direct comparisons between different studies but also to address deficits in the global knowledge on medication safety in mental health settings.
This review showed that MEs at the mental healthcare interface between secondary and primary care frequently present a risk of causing harm to patients [23, 48, 53] . However, the majority of these data were from secondary care, and little is known about the frequency of such errors after hospital discharge back to the community [63] [64] [65] . Evidence from the UK found that a ME occurs in 69.0% and 43.0% of medications at the time of admission to and discharge from mental health hospitals, respectively [66] . Other recent evidence from the USA suggests that 23.3% of psychiatric patients had at least one unintentional discrepancy at the time of hospital discharge [67] . These estimates clearly highlight the importance of medication reconciliation at care interfaces in mental health settings to improve safe care transfer [68, 69] . This is supported by recent studies reporting on the clinical benefit of medication reconciliation at the mental healthcare interface [66, 67, 70, 71] . Accordingly, a recent national UK survey [72] found that medication reconciliation is now common practice in the majority of mental health services in the UK. Further research is required to identify the burden of MEs at interfaces between mental healthcare settings.
Few studies have been published that evaluate interventions to reduce the number of MEs in mental health hospitals [24, 48, 73] . A study based in a US psychiatric hospital found that using a personal digital assistant (PDA) reduced the rate of MEs in discharge lists from 18.0 to 8.0% [48] . Another study investigated the effectiveness of implementing a provider order entry (POE) programme to reduce error in mental health hospitals [73] . However, none of these studies described the type of MEs involved or their potential to cause harm to patients. Another UK-based study examined the impact on the rate of MAEs of implementing an automated dispensing cabinet in a mental health hospital; it found the cabinet to be associated with a reduction in MAE rate from 8.9 to 7.2% as well as a reduction in the time spent by nurses administering medication from 2.9 to 2.3 min per dose [24] . However, implementing a successful intervention to reduce the number of MEs in a hospital is largely based on understanding the causes and risk factors associated with their occurrence [74] [75] [76] . Although this is beyond the scope of this study, some of the included studies highlighted some of the risk factors associated with the occurrence of MEs in mental health hospitals [22, 23, 25] , and the first in-depth qualitative study of the causes of MAEs in this setting has emerged [77] . Future qualitative studies are needed to identify the root causes and risk factors associated with MEs and ADEs in mental health hospitals to help design effective remedial interventions.
To our knowledge, this is the most up-to-date systematic appraisal of the evidence examining the frequency, nature and severity of MEs and ADEs in mental health hospitals. A comprehensive search strategy was used to identify eligible studies from a wide range of databases without language restriction, and the reference lists of included studies and relevant review papers were manually searched. Moreover, our inclusion criteria with respect to study designs were stricter than previously published systematic reviews [19, 20] , as we excluded studies based only on incident reports as the sole method of data collection. However, we were faced with a number of limitations in the studies identified-heterogeneity in the denominator used, the population involved, and the outcome definition-which limited the opportunity for direct comparisons between different studies. In addition, studies differed in the way they presented the classification of drugs involved in MEs/ADEs, with some not reporting any at all. Likewise, different schemes were used to classify error subtypes. This can be seen, for example, in some MAE studies that considered nurses' behaviour, such as unauthorized tablet crushing or failure to report patient identity, as an MAE whereas other studies did not-all of which eventually affected the reported MAE frequency. With this in mind, these specific study limitations should be considered when drawing conclusions from the findings of this review.
Conclusion
MEs and ADEs are common in mental health hospitals. Medication safety interventions should target risks associated with psychotropic medicines, especially at the prescribing and administration stages of the medicine use process. Further research is required to investigate the rate of DEs, unintentional discrepancies and ADEs in mental health hospitals. Future research should examine the underlying causes of MEs and ADEs so theory-based interventions can be developed and evaluated to improve patient safety in this specialist healthcare setting.
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